Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diode laser endophotocoagulation

M Sasoh1, W E Smiddy

  • 1Bascom Palmer Institute, University of Miami School of Medicine, Department of Ophthalmology, Florida, USA.

Retina (Philadelphia, Pa.)
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcranial Doppler enhanced thrombolysis for embolic occlusion of major cerebral arteries.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

Removal of Thelazia callipaeda from the subconjunctival space.

European journal of ophthalmology·2007
Same author

The use of colour Doppler imaging in the diagnosis of retinal detachment.

Eye (London, England)·2006
Same author

Exudative retinal detachment due to methicillin-resistant Staphylococcus aureus infection after scleral buckling in the treatment of retinal detachment accompanied by atopic dermatitis.

Retina (Philadelphia, Pa.)·2002
Same author

[Supraciliochoroidal fluid at an early stage after trabeculectomy].

Nippon Ganka Gakkai zasshi·2002
Same author

[Anterior chamber structural change in postural variation in pseudoexfoliation syndrome].

Nippon Ganka Gakkai zasshi·2001
Same journal

Persistent placoid maculopathy: long term outcomes and prognostic factors.

Retina (Philadelphia, Pa.)·2026
Same journal

ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES: A NOVEL SURGICAL TECHNIQUE.

Retina (Philadelphia, Pa.)·2026
Same journal

Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

Retina (Philadelphia, Pa.)·2026
Same journal

Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

Retina (Philadelphia, Pa.)·2026
See all related articles

Diode laser endophotocoagulation is a safe and effective treatment for various retinal conditions. This study found it comparable to argon laser treatment in improving visual acuity.

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Laser Therapy

Background:

  • Diode laser endophotocoagulation is a surgical technique used in ophthalmology.
  • Its utility, safety, and reliability require evaluation in large clinical series.

Purpose of the Study:

  • To assess the effectiveness and safety of diode laser endophotocoagulation.
  • To compare diode laser endophotocoagulation with argon laser treatment.

Main Methods:

  • Prospective study of 226 eyes treated with diode endophotocoagulation.
  • Indications included proliferative diabetic retinopathy, proliferative vitreoretinopathy, and retinal detachment.
  • Retrospective comparison with 67 eyes treated with argon endolaser photocoagulation.

Main Results:

Related Experiment Videos

  • Diode endophotocoagulation achieved the desired intraoperative effect in 99.6% of cases without complications.
  • Visual acuity improved in 71% of eyes treated with diode laser, with 70% achieving 5/200 or better.
  • No significant difference in visual improvement or final results was observed compared to argon laser treatment.

Conclusions:

  • Diode laser endophotocoagulation is a safe, reliable, and effective treatment option.
  • It demonstrates comparable outcomes to argon laser treatment for endophotocoagulation.